Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04843878 · ClinicalTrials.gov registry record
COVID-19 Testing Pilot Study
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 326
- Enrollment target
NCT04843878: Completed study, sponsored by University of Pennsylvania.
NCT04843878 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 326 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04843878 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the reliability of a low-cost rapid diagnostic test for COVID-19. The method of the testing procedure uses electrochemistry to detect COVID-19 spike proteins within human samples. To test the effectiveness of this new method, patients will be recruited as they present for testing at ambulatory Penn testing sites. Patients will be asked to self-collect one anterior nares samples under the supervision of authorized study personnel.
Interventions
- DIAGNOSTIC_TEST COVID Detect
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2021-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04843878
The ClinicalTrials.gov registry entry for NCT04843878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID Detect is the first listed.
NCT04843878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04843878 about?
NCT04843878 is a clinical study titled "COVID-19 Testing Pilot Study". The purpose of this study is to determine the reliability of a low-cost rapid diagnostic test for COVID-19. The method of the testing procedure uses electrochemistry to detect COVID-19 spike proteins within human samples. To test the effectiveness of this new method, patients will be recruited as th...
What is the current status of trial NCT04843878?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2021-01-05. Estimated completion is 2021-03-12.
What interventions are being tested in trial NCT04843878?
The interventions under investigation include: COVID Detect (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04843878?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.